Business BioLargo anticipates 2026 as a transformative year with Clyra Medical commercialization and battery joint ventures
Business Mistras Group targets $730M–$750M 2026 revenue with increased CapEx for aerospace and defense
Business Global Water Resources outlines $70M rate base expansion and signals focus on expense control for 2026
Business ImmuCell outlines plan to boost First Defense capacity to 5–6M units while strengthening U.S. market share
Business CorMedix outlines $300M–$320M revenue and $100M–$125M EBITDA targets for 2026 amid DefenCath transition and Melinta integration
Business NACCO outlines significant capital investments for 2026 amid utility coal mining recovery and new infrastructure contracts
Business Aquestive plans 75-rep Anaphylm launch and targets $46M–$50M in 2026 revenue while doubling medical affairs